Vidacare Corp.: Series D $7.6M

Posted in I - Series D, Q - 3Q09, R - SOUTH WEST, X - Device (Intraosseous), XX - TX

Vidacare (San Antonio, TX) a commercial-stage medical device company focused on enabling intraosseous access technologies, closed a $7.6M Series D financing. Participants include Piper Jaffray, Telegraph Hill Partners, Tullis Health Investors and Incyte Venture.

eCardio Diagnostics, Inc. Series B $10M*

Posted in I - Series B, Q - 3Q09, R - SOUTH WEST, X - Device (Cardiology), XX - TX

eCardio Diagnostics (The Woodlands, TX) a X-stage company focused on the diagnosis, monitoring and clinical management of cardiac arrhythmias, closed a $10M Series B financing.* Participants include Sequoia Capital.
*This statement estimates undisclosed financial information

Savara Pharmaceuticals, Inc.: Series A $1.0M

Posted in I - Series A, Q - 2Q09, R - SOUTH WEST, X - Device (Delivery), XX - TX

Savara Pharmaceuticals (Austin, TX) a preclinical-stage developer of dry powder and nebulized-based therapeutic inhalation drug delivery platform, closed a $1.0M Series A financing. Participants were not identified.

Glycos Biotechnologies, Inc.: Series A $5M

Posted in I - Series A, Q - 2Q09, R - SOUTH WEST, X - Biofuel, XX - TX

Glycos Biotechnologies (Houston, TX) a development-stage biofuels company focused on production of intermediate chemicals for biodegradable, non-degradable plastics, surfactants and fuels, closed a $5M Series A financing. Participants include Draper Fisher Jurvetson and DFJ Mercury.

Molecular Templates, Inc.: Series A $2.5M

Posted in I - Series A, Q - 2Q09, R - SOUTH WEST, X - Oncology, X - Therapeutic Platform, XX - TX

Molecular Templates (Austin, TX) a preclinical-stage company focused on a protein platform for the development of melanoma and other oncology therapeutics, closed a $2.5M Series A financing. Participants include Santé Ventures.

Next Entries »

to top of page...